NHS approves new one-time leukaemia cure therapy
The NHS has approved a groundbreaking, one-time CAR T-cell therapy for leukaemia, offering new hope with high remission rates and fewer side-effects for patients across England.
The NHS has approved a groundbreaking, one-time CAR T-cell therapy for leukaemia, offering new hope with high remission rates and fewer side-effects for patients across England.
Groundbreaking research reveals mRNA Covid vaccines may extend cancer patient survival by 17 months. Discover how this low-cost treatment could revolutionise oncology.